Genome Edited B Cells: A New Frontier in Immune Cell Therapies

0
285
Investigators discuss the potential of engineered B cells as a cell therapy, the challenges involved in editing the Ig locus and the advances that are making this possible, and envision future directions for this emerging field of immune cell engineering.
[Molecular Therapy]
AbstractGraphical Abstract